FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Wuhan Bingbing Pharmaceutical LidoPatch Recall

LidoPatch (lidocaine HCl 3

Wuhan Bingbing Pharmaceutical Co., Ltd. · Wuhan, N/A

Risk level
Class II
Reported by FDA
Jun 3, 2020
Recall ID
D-1277-2020
Check your lot numberHow we source this data

Summary

Wuhan Bingbing Pharmaceutical recalled LidoPatch starting May 19, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1277-2020 on Jun 3, 2020. Reason: CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date. Status: Ongoing.

Why it was recalled

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Product description

LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.

Lot numbers, UPCs & expiration codes

Batch #: 1180103, Exp 2021.01.02; 180104, Exp 2021.01.03; 80105, Exp 2021.01.04; 180106, Exp 2021.01.05; 80107, Exp 2021.01.06.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1277-2020
Classification
Class II
Status
Ongoing
Recall initiated
May 19, 2020
FDA report date
Jun 3, 2020
Quantity
4,960 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Wuhan Bingbing Pharmaceutical Co., Ltd.

Original FDA data

Every field from FDA enforcement report D-1277-2020, exactly as published.

Show all FDA fields
City
Wuhan
Status
Ongoing
Country
China
Event ID
85726
Address
Building
Address (line 2)
F, No.5, Kangda Street
Code information
Batch #: 1180103, Exp 2021.01.02; 180104, Exp 2021.01.03; 80105, Exp 2021.01.04; 180106, Exp 2021.01.05; 80107, Exp 2021.01.06.
Report date
Jun 3, 2020
Product type
Drugs
Recall number
D-1277-2020
Classification
Class II
Recalling firm
Wuhan Bingbing Pharmaceutical Co., Ltd.
Product quantity
4,960 boxes
Reason for recall
CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.
Voluntary / mandated
Voluntary: Firm initiated
Product description
LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.
Distribution pattern
Nationwide in the USA
Recall initiation date
May 19, 2020
Initial firm notification
E-Mail
Center classification date
May 28, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1277-2020, published Jun 3, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls